Diovan T30230+Tab+HY


Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 96.3%
Essential Hypertension 2.2%
Prophylaxis 0.7%
Diabetes Mellitus 0.4%
Gastrooesophageal Reflux Disease 0.4%
Death 16.7%
Cerebral Infarction 7.6%
Pneumonia 7.6%
Blood Uric Acid Increased 6.1%
Hyperkalaemia 6.1%
Loss Of Consciousness 6.1%
Cardiac Failure 4.5%
Dialysis 4.5%
Oropharyngeal Discomfort 4.5%
Stent Placement 4.5%
Vomiting 4.5%
Atrial Fibrillation 3.0%
Atrioventricular Block 3.0%
Blood Urea Increased 3.0%
Brain Stem Haemorrhage 3.0%
Dehydration 3.0%
Heart Rate Decreased 3.0%
High Density Lipoprotein Increased 3.0%
Hypertensive Heart Disease 3.0%
Metastases To Abdominal Cavity 3.0%
Secondary
Hypertension 93.6%
Essential Hypertension 6.4%
Orthostatic Hypotension 12.7%
Loss Of Consciousness 11.1%
Pneumonia Aspiration 9.5%
Blood Urea Increased 7.9%
Vomiting 6.3%
Heat Illness 4.8%
Hyperkalaemia 4.8%
Vasodilatation 4.8%
Blood Uric Acid Increased 3.2%
Cardiac Failure 3.2%
Dehydration 3.2%
Dialysis 3.2%
Heart Rate Decreased 3.2%
Low Density Lipoprotein Increased 3.2%
Paresis 3.2%
Rehabilitation Therapy 3.2%
Renal Neoplasm 3.2%
Shunt Occlusion 3.2%
Toxic Skin Eruption 3.2%
White Blood Cell Count Decreased 3.2%

Drug Data